Trial site
Pune
- 10running trials
- 8closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease3 trials
- Stroke3 trials
- Chronic myeloid leukaemia2 trials
- Familial hypercholesterolaemia2 trials
- Lupus (SLE)2 trials
- Metastatic breast cancer2 trials
- Multiple sclerosis2 trials
- Myeloproliferative neoplasms2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Gastric and oesophageal cancer1 trial
- Lung cancer1 trial
- and 3 more
- Phase
- Phase 311 trials
- Phase 44 trials
- Phase 22 trials
- Status
- Active, not recruiting8 trials
- Completed7 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals18 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lupus (SLE)1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Completed
Completed
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Completed
Completed
Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world
Terminated
Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026